Genetic risk factors in eating disorders

American Journal of PharmacoGenomics

Volumn 4, Issue 4, 2004, Pages 209-223

  Hinney, Anke ^a,b   Friedel, Susann ^a   Remschmidt, Helmut ^a   Hebebrand, Johannes ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Clinical Research Group   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AGOUTI RELATED PROTEIN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA 3 ADRENERGIC RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ACTIVATED POTASSIUM CHANNEL; CATECHOL METHYLTRANSFERASE; CLOZAPINE; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; LEPTIN; MELANOCORTIN 4 RECEPTOR; NEUROPEPTIDE Y; NORADRENALIN; PROOPIOMELANOCORTIN; PROTEOLIPID PROTEIN; RYANODINE RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA NERVOSA; BINGE EATING DISORDER; BODY WEIGHT; BULIMIA; CHROMOSOME 1; CHROMOSOME 10P; CHROMOSOME 3; CHROMOSOME 4; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EATING DISORDER; FAMILY STUDY; GENETIC RISK; HUMAN; LINKAGE ANALYSIS; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PUBERTY; RAT; REVIEW; SEROTONINERGIC SYSTEM; SWINE; TWINS; WASTING SYNDROME;

ANIMALS; DISEASE MODELS, ANIMAL; EATING DISORDERS; HUMANS; LINKAGE (GENETICS); PUBERTY; RISK FACTORS; TWIN STUDIES;

AGOUTI; ANIMALIA; SUS SCROFA;

EID: 4344649532     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200404040-00001     Document Type: Review

References (150)

1. Kaye W, Strober M. The neurobiology of eating disorders. In: Charney DS, Nestler EJ, Bunney BS, editors. Neurobiological foundations of mental illness. New York: Oxford University Press, 1999: 891-906
2. Bulik CM, Sullivan PF, Wade TD, et al. Twin studies of eating disorders: a review. Int J Eat Disord 2000 Jan; 27 (1): 1-20
3. Fairburn CG, Harrison PJ. Eating disorders. Lancet 2003 Feb 1; 361 (9355): 407-16
4. Gorwood P, Kipman A, Foulon C. The human genetics of anorexia nervosa. Eur J Pharmacol 2003 Nov 7; 480 (1-3): 163-70
5. Kaye WH, Lilenfeld LR, Berrettini WH, et al. A search for susceptibility loci for anorexia nervosa: methods and sample description. Biol Psychiatry 2000 May 1; 47 (9): 794-803
6. Collier DA, Arranz MJ, Li T, et al. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa [letter]. Lancet 1997 Aug 9; 350 (9075): 412
7. Sorbi S, Nacmias B, Tedde A, et al. 5-HT2A promoter polymorphism in anorexia nervosa [letter]. Lancet 1998 Jun 13; 351 (9118): 1785
8. Enoch MA, Kaye WH, Rotondo A, et al. 5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 1998 Jun 13; 351 (9118): 1785-6
9. Nacmias B, Ricca V, Tedde A, et al. 5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa. Neurosci Lett 1999 Dec 24; 277 (2): 134-6
10. Ziegler A, Hebebrand J, Gorg T, et al. Further lack of association between the 5-HT2A gene promoter polymorphism and susceptibility to eating disorders and a meta-analysis pertaining to anorexia nervosa. Mol Psychiatry 1999 Sep; 4 (5): 410-2
11. Hinney A, Ziegler A, Nothen MM, et al. 5-HT2A receptor gene polymorphisms, anorexia nervosa, and obesity. Lancet 1997 Nov 1; 350 (9087): 1324-5
12. Campbell DA, Sundaramurthy D, Markham AF, et al. Lack of association between 5-HT2A gene promoter polymorphism and susceptibility to anorexia nervosa [letter]. Lancet 1998 Feb 14; 351 (9101): 499
13. Gorwood P, Ades J, Bellodi L, et al. The 5-HT(2A)-1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres. Mol Psychiatry 2002; 7 (1): 90-4
14. Grice DE, Halmi KA, Fichter MM, et al. Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum Genet 2002 Mar; 70 (3): 787-92
15. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
16. Bergen AW, van den Bree MB, Yeager M, et al. Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Mol Psychiatry 2003 Apr; 8 (4): 397-406
17. Devlin B, Bacanu SA, Klump KL, et al. Linkage analysis of anorexia nervosa incorporating behavioral covariates. Hum Mol Genet 2002 Mar 15; 11 (6): 689-96
18. Bulik CM, Devlin B, Bacanu SA, et al. Significant linkage on chromosome 10p in families with bulimia nervosa. Am J Hum Genet 2003 Jan; 72 (1): 200 Epub 2002 Dee 10-207
19. Hager J, Dina C, Francke S, et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 1998 Nov; 20 (3): 304-8
20. Saar K, Geller F, Ruschendorf F, et al. Genome scan for childhood and adolescent obesity in German families. Pediatrics 2003 Feb; 111 (2): 321-7
21. World Health Organization. ICD-10. International classification of mental and behavioural disorders: clinical description and diagnostic guidelines. Geneva: WHO, 1992
22. Strober M, Freeman R, Lampert C, et al. Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry 2000 Mar; 157 (3): 393-401
23. Walters EE, Neale MC, Eaves LJ, et al. Bulimia nervosa and major depression: a study of common genetic and environmental factors. Psychol Med 1992 Aug; 22 (3): 617-22
24. Lilenfeld LR, Kaye WH, Greeno CG, et al. A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry 1998 Jul; 55 (7): 603-10
25. Klump KL, Holly A, Iacono WG, et al. Physical similarity and twin resemblance for eating attitudes and behaviors: a test of the equal environments assumption. Behav Genet 2000 Jan; 30 (1): 51-8
26. Plomin R, Willerman L, Loehlin JC. Resemblance in appearance and the equal environments assumption in twin studies of personality traits. Behav Genet 1976 Jan; 6 (1): 43-52
27. Holland AJ, Hall A, Murray R, et al. Anorexia nervosa: a study of 34 twin pairs and one set of triplets. Br J Psychiatry 1984; 145: 414-9
28. Holland AJ, Sicotte N, Treasure J. Anorexia nervosa: evidence for a genetic basis. J Psychosom Res 1988; 32: 561-71
29. Bulik CM, Sullivan PF, Kendler KS. Heritability of binge-eating and broadly defined bulimia nervosa. Biol Psychiatry 1998 Dec 15; 44 (12): 1210-8
30. Kendler KS, MacLean C, Neale M, et al. The genetic epidemiology of bulimia nervosa. Am J Psychiatry 1991 Dec; 148 (12): 1627-37
31. Kendler KS, Walters EE, Neale MC, et al. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 1995 May; 52 (5): 374-83
32. Kortegaard LS, Hoerder K, Joergensen J, et al. A preliminary population-based twin study of self-reported eating disorder. Psychol Med 2001 Feb; 31 (2): 361-5
33. Wade TD, Bulik CM, Neale M, et al. Anorexia nervosa and major depression: shared genetic and environmental risk factors. Am J Psychiatry 2000 Mar; 157 (3): 469-71
34. Hebebrand J, Remschmidt H. Anorexia nervosa viewed as an extreme weight condition: genetic implications. Hum Genet 1995 Jan; 95 (1): 1-11
35. Kipman A, Gorwood P, Mouren-Simeoni MC, et al. Genetic factors in anorexia nervosa. Eur Psychiatry 1999 Jul; 14 (4): 189-98
36. Klump KL, Miller KB, Keel PK, et al. Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol Med 2001 May; 31 (4): 737-40
37. Klump KL, Kaye WH, Strober M. The evolving genetic foundations of eating disorders. Psychiatr Clin North Am 2001 Jun; 24 (2): 215-25
38. Klump KL, Wonderlich S, Lehoux P, et al. Does environment matter?: a review of nonshared environment and eating disorders. Int J Eat Disord 2002 Mar; 31 (2): 118-35
39. Steinle NI, Hsueh WC, Snitker S, et al. Eating behavior in the Old Order Amish: heritability analysis and a genome-wide linkage analysis. Am J Clin Nutr 2002 Jun; 75 (6): 1098-106
40. Walters EE, Kendler KS. Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample. Am J Psychiatry 1995 Jan; 152 (1): 64-71
41. Siegfried Z, Berry EM, Hao S, et al. Animal models in the investigation of anorexia. Physiol Behav 2003 Jun; 79 (1): 39-45
42. Exner C, Hebebrand J, Remschmidt H, et al. Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa. Mol Psychiatry 2000 Sep; 5 (5): 476-81
43. Hebebrand J, Exner C, Hebebrand K, et al. Hyperactivity in patients with anorexia nervosa and in semistarved rats: evidence for a pivotal role of hypoleptinemia. Physiol Behav 2003 Jun; 79 (1): 25-37
44. Son JH, Baker H, Park DH, et al. Drastic and selective hyperinnervation of central serotonergic neurons in a lethal neurodevelopmental mouse mutant, Anorexia (anx). Brain Res Mol Brain Res 1994 Aug; 25 (1-2): 129-34
45. Chun HS, Park Y, Yang YK, et al. Identification of genes showing differential expression in anorexia mutant mouse. Neuroreport 2003 May 23; 14 (7): 1055-9
46. Johansen JE, Fetissov S, Fischer H, et al. Approaches to anorexia in rodents: focus on the anx/anx mouse. Eur J Pharmacol 2003 Nov 7; 480 (1-3): 171-6
47. Treasure JL, Owen JB. Intriguing links between animal behavior and anorexia nervosa. Int J Eat Disord 1997 May; 21 (4): 307-11
48. Nelson TE. Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins. Curr Mol Med 2002 Jun; 2 (4): 347-69
49. Roehe R, Plastow GS, Knap PW. Quantitative and molecular genetic determination of protein and fat deposition. Homo 2003; 54 (2): 119-31
50. Hagan MM, Wauford PK, Chandler PC, et al. A new animal model of binge eating: key synergistic role of past caloric restriction and stress. Physiol Behav 2002 Sep; 77 (1): 45-54
51. Bulik CM, Sullivan PF, Fear J, et al. Predictors of the development of bulimia nervosa in women with anorexia nervosa. J Nerv Ment Dis 1997 Nov; 185 (11): 704-7
52. Hsu LK, Sobkiewicz TA. Bulimia nervosa: a four- to six-year follow-up study. Psychol Med 1989 Nov; 19 (4): 1035-8
53. Kaye WH, Klump KL, Frank GK, et al. Anorexia and bulimia nervosa. Annu Rev Med 2000; 51: 299-313
54. Koronyo-Hamaoui M, Danziger Y, Frisch A, et al. Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study. Mol Psychiatry 2002; 7 (1): 82-5
55. Kaye WH, Berrettini W, Gwirtsman H, et al. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 1990 Jun; 47 (6): 548-56
56. Kaye WH, Greeno CG, Moss H, et al. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 1998 Oct; 55 (10): 927-35
57. Frey J, Hebebrand J, Muller B, et al. Reduced body fat in long-term followed-up female patients with anorexia nervosa. J Psychiatr Res 2000 Jan-Feb; 34 (1): 83-8
58. Hebebrand J, Blum WF, Barth N, et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 1997 Jul; 2 (4): 330-4
59. Frisch A, Laufer N, Danziger Y, et al. Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients. Mol Psychiatry 2001 Mar; 6 (2): 243-5
60. Hinney A, Schneider J, Ziegler A, et al. No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, under-weight, and obesity. Am J Med Genet 1999 Dec 15; 88 (6): 594-7
61. Bruins-Slot L, Gorwood P, Bouvard M, et al. Lack of association between anorexia nervosa and D3 dopamine receptor gene. Biol Psychiatry 1998 Jan 1; 43 (1): 76-8
62. Han L, Nielsen DA, Rosenthal NE, et al. No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism. Biol Psychiatry 1999 Mar 1; 45 (5): 615-9
63. Hinney A, Barth N, Ziegler A, et al. Serotonin transporter gene-linked polymorphic region: allele distributions in relationship to body weight and in anorexia nervosa. Life Sci 1997; 61 (21): PL 295-303
64. DiBella DD, Catalano M, Cavallini MC, et al. Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa. Mol Psychiatry 2000 May; 5 (3): 233-4
65. Sundaramurthy D, Pieri LF, Gape H, et al. Analysis of the serotonin transporter gene linked polymorphism (5-HTTLPR) in anorexia nervosa. Am J Med Genet 2000 Feb 7; 96 (1): 53-5
66. Fumeron F, Betoulle D, Aubert R, et al. Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake. Mol Psychiatry 2001 Jan; 6 (1): 9-10
67. Urwin RE, Bennetts BH, Wilcken B, et al. Investigation of epistasis between the serotonin transporter and norepinephrine transporter genes in anorexia nervosa. Neuropsychopharmacology 2003 Jul; 28 (7): 1351-5
68. Levitan RD, Kaplan AS, Masellis M, et al. Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry 2001 Oct 15; 50 (8): 640-3
69. Hinney A, Herrmann H, Lohr T, et al. No evidence for an involvement of alleles of polymorphisms in the serotonin 1Dbeta and 7 receptor genes in obesity, under-weight or anorexia nervosa. Int J Obes Relat Metab Disord 1999 Jul; 23 (7): 760-3
70. Kipman A, Bruins-Slot L, Boni C, et al. 5-HT(2A) gene promoter polymorphism as a modifying rather than a vulnerability factor in anorexia nervosa. Eur Psychiatry 2002 Jul; 17 (4): 227-9
71. Nishiguchi N, Matsushita S, Suzuki K, et al. Association between 5-HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients. Biol Psychiatry 2001 Jul 15; 50 (2): 123-8
72. Ando T, Komaki G, Karibe M, et al. 5-HT2A promoter polymorphism is not associated with anorexia nervosa in Japanese patients. Psychiatr Genet 2001 Sep; 11 (3): 157-60
73. Rybakowski F, Slopien A, Dmitrzak-Weglarz M, et al. Association study of 5-HT2A receptor gene polymorphism in anorexia nervosa in Polish population [in Polish]. Psychiatr Pol 2003; 37 (1): 47-55
74. Ricca V, Nacmias B, Cellini E, et al. 5-HT2A receptor gene polymorphism and eating disorders. Neurosci Lett 2002 Apr 26; 323 (2): 105-8
75. Burnet PW, Smith KA, Cowen PJ, et al. Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder. Psychiatr Genet 1999 Jun; 9 (2): 101-4
76. Hu X, Giotakis O, Li T, et al. Association of the 5-HT2c gene with susceptibility and minimum body mass index in anorexia nervosa. Neuroreport 2003; 14 (6): 781-3
77. Urwin RE, Bennetts B, Wilcken B, et al. Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region. Mol Psychiatry 2002; 7 (6): 652-7
78. Hinney A, Bornscheuer A, Depenbusch M, et al. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region. Mol Psychiatry 1998 Nov; 3 (6): 539-43
79. Rosenkranz K, Hinney A, Ziegler A, et al. Screening for mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes. Int J Obes Relat Metab Disord 1998 Feb; 22 (2): 157-63
80. Vink T, Hinney A, van Elburg AA, et al. Association between an agouti-related protein gene polymorphism and anorexia nervosa. Mol Psychiatry 2001 May; 6 (3): 325-8
81. Hinney A, Becker I, Heibult O, et al. Systematic mutation screening of the proopiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. J Clin Endocrinol Metab 1998 Oct; 83 (10): 3737-41
82. Hinney A, Schmidt A, Nottebom K, et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999 Apr; 84 (4): 1483-6
83. Ribases M, Gratacos M, Armengol L, et al. Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 2003 Aug; 8 (8): 745-51
84. Hinney A, Lentes KU, Rosenkranz K, et al. Beta 3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, under-weight or anorexia nervosa. Int J Obes Relat Metab Disord 1997 Mar; 21 (3): 224-30
85. Campbell DA, Sundaramurthy D, Gordon D, et al. Association between a marker in the UCP-2/UCP-3 gene cluster and genetic susceptibility to anorexia nervosa. Mol Psychiatry 1999 Jan; 4 (1): 68-70
86. Hu X, Murphy F, Karwautz A, et al, Analysis of microsatellite markers at the UCP2/UCP3 locus on chromosome 11q13 in anorexia nervosa. Mol Psychiatry 2002; 7 (7): 814
87. Ando T, Ishikawa T, Kawamura N, et al. Analysis of tumor necrosis factor-alpha gene promoter polymorphisms in anorexia nervosa. Psychiatr Genet 2001 Sep; 11 (3): 161-4
88. Rosenkranz K, Hinney A, Ziegler A, et al. Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab 1998 Dec; 83 (12): 4524-7
89. Eastwood H, Brown KM, Markovic D, et al. Variation in the ESRI and ESR2 genes and genetic susceptibility to anorexia nervosa. Mol Psychiatry 2002; 7 (1): 86-9
90. Blundell JE, Lawton CL, Halford JC, Serotonin, eating behavior, and fat intake. Obes Res 1995 Nov; 3 Suppl. 4: 471S-6S
91. Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med 2000 Apr; 32 (3): 222-32
92. Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Adv Exp Med Biol 1996; 398: 35-41
93. Brewerton TD, Jimerson DC. Studies of serotonin function in anorexia nervosa. Psychiatry Res 1996 Apr 16; 62 (1): 31-42
94. Jimerson DC, Lesem MD, Kaye WH, et al. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 1992 Feb; 49 (2): 132-8
95. Kaye WH, Gwirtsman HE, George DT, et al. Altered serotonin activity in anorexia nervosa after long-term weight restoration: does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry 1991 Jun; 48 (6): 556-62
96. Hinney A, Remschmidt H, Hebebrand J. Candidate gene polymorphisms in eating disorders. Eur J Pharmacol 2000 Dec 27; 410 (2-3): 147-59
97. Gorwood P. Eating disorders, serotonin transporter polymorphisms and potential treatment response. Am J Pharmacogenomics 2004; 4 (1): 9-17
98. Barry VC. Klawans HL. On the role of dopamine in the pathophysiology of anorexia nervosa. J Neural Transm 1976; 38 (2): 107-22
99. Golden NH, Shenker IR. Amenorrhea in anorexia nervosa: neuroendocrine control of hypothalamic dysfunction. Int J Eat Disord 1994 Jul; 16 (1): 53-60
100. Terry P, Gilbert DB, Cooper SJ. Dopamine receptor subtype agonists and feeding behavior. Obes Res 1995 Nov; 3 Suppl. 4: 515S-23S
101. Zhou QY, Palmiter RD. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 1995 Dec 29; 83 (7): 1197-209
102. Rubinstein M, Phillips TJ, Bunzow JR, et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 1997 Sep 19; 90 (6): 991-1001
103. Nöthen MM, Cichon S, Hemmer S, et al. Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Hum Mol Genet 1994 Dec; 3 (12): 2207-12
104. Van Tol HH, Bunzow JR, Guan HC, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991 Apr 18; 350 (6319): 610-4
105. Brömel T, Blum WF, Ziegler A, et al. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 1998 Jan; 3 (1): 76-80
106. Kaye WH, Jimerson DC, Lake CR, et al. Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa. Psychiatry Res 1985 Apr; 14 (4): 333-42
107. Pirke KM, Kellner M, Philipp E, et al. Plasma norepinephrine after a standardized test meal in acute and remitted patients with anorexia nervosa and in healthy controls. Biol Psychiatry 1992 May 15; 31 (10): 1074-7
108. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 Dec 1; 372 (6505): 425-32
109. Hebebrand J, van der Heyden J, Devos R, et al. Plasma concentrations of obese protein in anorexia nervosa. Lancet 1995 Dec; 346 (8990): 1624-5
110. Haluzik M, Papezova M, Nedvidkova J, et al. Serum leptin levels in patients with anorexia nervosa before and after partial refeeding, relationships to serum lipids and biochemical nutritional parameters. Physiol Res 1999; 48 (3): 197-202
111. Gendall KA, Kaye WH, Altemus M, et al. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry 1999 Jul 15; 46 (2): 292-9
112. Stanley BG, Leibowitz SF. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 1984 Dec 24; 35 (26): 2635-42
113. Grundemar L, Hakanson R. Neuropeptide Y effector systems: perspectives for drug development. Trends Pharmacol Sci 1994 May; 15 (5): 153-9
114. Chua Jr SC, Brown AW, Kim J, et al. Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. Brain Res Mol Brain Res 1991 Oct; 11 (3-4): 291-9
115. Wilding JP, Gilbey SG, Bailey CJ, et al. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 1993 May; 132 (5): 1939-44
116. Koehnke MD, Schick S, Lutz U, et al. Severity of alcohol withdrawal symptoms and the T1 128C polymorphism of the neuropeptide Y gene. J Neural Transm 2002 Nov; 109 (11): 1423-9
117. Lappalainen J, Kranzler HR, Malison R, et al. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch Gen Psychiatry 2002 Sep; 59 (9): 825-31
118. Holderness CC, Brooks-Gunn J, Warren MP. Co-morbidity of eating disorders and substance abuse review of the literature. Int J Eat Disord 1994 Jul; 16 (1): 1-34
119. Silva AP, Cavadas C, Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 2002 Dec; 326 (1-2): 3-25
120. Adan RA, Kas MJ. Inverse agonism gains weight. Trends Pharmacol Sci 2003 Jun; 24 (6): 315-21
121. Huang XF, Han M, South T, et al. Altered levels of POMC, AgRP and MC4-R mRNA expression in the hypothalamus and other parts of the limbic system of mice prone or resistant to chronic high-energy diet-induced obesity. Brain Res 2003 Nov 28; 992 (1): 9-19
122. Sainsbury A, Cooney GJ, Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab 2002 Dec; 16 (4): 623-37
123. Argyropoulos G, Rankinen T, Neufeld DR, et al. A polymorphism in the human agouti-related protein is associated with late-onset obesity. J Clin Endocrinol Metab 2002 Sep; 87 (9): 4198-202
124. Yeo GS, Farooqi IS, Aminian S, et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998 Oct; 20 (2): 111-2
125. Vaisse C, Clement K, Guy-Grand B, et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998 Oct; 20 (2): 113-4
126. Vaisse C, Clement K, Durand E, et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000 Jul; 106 (2): 253-62
127. Hinney A, Hohmann S, Geller F, et al. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 2003 Sep; 88 (9): 4258-67
128. Sina M, Hinney A, Ziegler A, et al. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am J Hum Genet 1999 Dec; 65 (6): 1501-7
129. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000 Jul; 106 (2): 271-9
130. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997 Jan 10; 88 (1): 131-41
131. Keefe PH, Wyshogrod D, Weinberger E, et al. Binge eating and outcome of behavioral treatment of obesity: a preliminary report. Behav Res Ther 1984; 22: 319-21
132. Rand CSW, Kuldau JM. Eating patterns in normal weight individuals: Bulimia, reastrained eating and the night eating syndrome. Int J Eat Disord 1986; 5: 75-84
133. Hudson JI, Pope Jr HG, Wurtman J, et al. Bulimia in obese individuals: relationship to normal-weight bulimia. J Nerv Ment Dis 1988; 176: 144-52
134. Mitchell JE, Pyle RL, Eckert ED, et al. Bulimia nervosa in overweight individuals. J Nerv Ment Dis 1990; 178: 324-7
135. Hebebrand J, Fichter M, Gerber G, et al. Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene. Mol Psychiatry 2002; 7 (6): 647-51
136. Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 348 (12): 1096-103
137. Geller F, Reichwald K, Dempfle A, et al. Melanocortin-4 receptor gene variant i103 is negatively associated with obesity. Am J Hum Genet 2004 Mar; 74 (3): 572-581 Epub 2004 Feb 17
138. Herpertz S, Siffert W, Hebebrand J. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 349 (6): 606-9
139. Hebebrand J, Geller F, Dempfle A, et al. Binge eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations. Mol Psychiatry 2004 Mar 23. Epub ahead of print
140. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 2000 Mar 15; 19 (6): 1290-300
141. Xu B, Goulding EH, Zang K, et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 2003 Jul; 6 (7): 736-42
142. Egan MF, Kojima M. Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003 Jan 24; 112 (2): 257-69
143. Clapham JC, Arch JR, Chapman H, et al. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000 Jul 27; 406 (6794): 415-8
144. Young JK. Estrogen and the etiology of anorexia nervosa. Neurosci Biobehav Rev 1990; 15 (3): 327-31
145. Hinney A, Ziegler A, Oeffner F, et al. Independent confirmation of a major locus for obesity on chromosome 10 [published erratum appears in J Clin Endocrinol Metab 2000 Nov; 85 (11): 3972]. J Clin Endocrinol Metab 2000 Aug; 85 (8): 2962-5
146. Hinney A, Ziegler A, Oeffner F, et al. Independent confirmation of a major locus for obesity on chromosome 10 [published erratum appears in J Clin Endocrinol Metab 2000 Nov; 85 (11): 3972]. J Clin Endocrinol Metab 2000 Aug; 85 (8): 2962-5
147. Price RA, Li WD, Bernstein A, et al. A locus affecting obesity in human chromosome region 10p12. Diabetologia 2001 Mar; 44 (3): 363-6
148. Dong C, Wang S, Li WD, et al. Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am J Hum Genet 2003 Jan; 72 (1): 115-24
149. Karwautz A, Rabe-Hesketh S, Hu X, et al. Individual-specific risk factors for anorexia nervosa: a pilot study using a discordant sister-pair design. Psychol Med 2001 Feb; 31 (2): 317-29
150. Chagnon YC, Rankinen T, Snyder EE, et al. The human obesity gene map: the 2002 update. Obes Res 2003 Mar; 11 (3): 313-67